Navigation Links
Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009
Date:12/9/2009

Remediation biotechnology firm announces opening of its Brazilian regional office

Chicago, Ill. (Vocus) December 9, 2009 -- As part of ongoing efforts to expand deployment of 21st century environmental biotechnologies across the globe, The Adventus Group, a world leader in the contaminated soil, sediment and groundwater remediation industry, is pleased to announce formal establishment of its independent office in Sao Paolo, Brazil. Increasing demand for access to scientifically defensible, field-proven and cost-efficient biotechnologies has driven establishment of a dedicated office in this rapidly developing country. Business operations will be managed by Ms. Josephine Molin, and will serve as Adventus’ business development hub for Brazil and Latin America.

Dr. Jim Mueller, President of Adventus Americas Inc., stated "Over the past two years, our staff has worked hard in the Brazilian marketplace, successfully partnering with local environmental remediation professionals to facilitate the introduction of In Situ Chemical Reduction (ISCR™) and other innovative biotechnologies. SGW Services Engenharia Ambiental Ltda. in particular, was very effective in getting our technologies accepted and effectively applied to remediate various impacted sites, and we are very appreciative of their support".

A number of project successes for heavy metals, chlorinated solvents and pesticides in soil and groundwater have been achieved in Brazil. Some project details are available via these links:

 

"The establishment of Adventus Brazil as an independent company allows us to better serve an increasing array of clients and technology end-users," stated Ms. Josephine Molin, Adventus' Manager of Brazilian Operations. “Our commitment is to best serve the entire engineering community across the territory Brazil by offering timely, confidential and professional remedial design support and technology implementation".

Office Address:
Avenida Paulista, nº 37 — 4º andar
Ed. Parque Cultural Paulista
CEP: 01311-902
São Paulo, SP - Brasil
Telephone: +55 (11) 2246-2759
Fax: +55 (11) 2246-2799

Employment Opportunity

Now Hiring: Remediation Technology Representative, Adventus Brasil

During a time when many remediation technology vendors are drastically cutting staff, the demand for Adventus' trademark biotechnologies and renowned client support have driven impressive increases in demand throughout 2009. We expect this trend to accelerate into 2010 and beyond, and are excited about offering this ground-floor opportunity. Interested candidates should email their full Curriculum Vitae with an accompanying cover letter to include salary expectations, to Josephine.Molin(at)adventusgroup(dot)com(dot)br. Full confidentiality is assured.

Job Description: The technology representative will work directly with consultants and end-users to provide remedial design support and cost estimates to facilitate the safe, scientifically valid application of our biotechnologies, considering site specific geochemistry, hydrogeology and treatment goals. The local representative will be continuously supported and trained by senior staff from Adventus Group in the USA and Canada. Work will include preparation of site-specific design and cost estimates for application of our technologies, technical support to customers, field support in connection with product application, translation of Adventus marketing materials and proposals, technical sales presentations and representation of Adventus technologies at various trade shows and conferences.

Background: Environmental engineering, hydrogeology or environmental scientist specializing in remediation or (bio)geochemistry.

Work experience: Entry-level position - 1 to 3 years of relevant experience required.

Language Skills: Fluent in English and Portuguese (speak, write, read) required.

Location: Near Sao Paulo, no relocation provided.

Work Status: Full- or Part-time, with the ability to work virtually (Home office)

Travel: Up to 25% domestic travel.

About Adventus Group – Environmental Biotechnologies for the 21st Century

The Adventus Group provides a growing portfolio of leading environmental remediation technologies, including patented offerings from Adventus Americas Inc., and EnviroMetal Technologies Inc. Our business model supports site owners, environmental engineers, consultants, regulators, and the academic community by providing unbiased design, and selection of the most cost-effective remediation strategies.

Adventus exclusively offers DARAMEND®, EHC® and related ZVI technologies for In Situ Chemical Reduction (ISCR™) along with TERRAMEND®, AQUABLOK+™, EHC-O®, O-SOX™, and mGCW™ systems to address myriad soil, sediment and groundwater impacts. Our world-class technical team is a clearly recognized industry leader. Since its inception in 2003, Adventus has successfully deployed field installations across North America, South America, Europe, Asia, and Oceania.

The ADVENTUS family of companies is always seeking strategic partnerships with complementary remediation biotechnologies, and qualified international licensees in numerous countries. For more information contact Mike Mueller at mike.mueller(at)AdventusGroup(dot)com. Visit us at www.AdventusGroup.com

###

Read the full story at http://www.prweb.com/releases/groundwater/contaminated_soil/prweb3313614.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. The Worlds First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference
2. GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress
3. China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information
4. DONG Energy and Inbicon Inaugurate One of the Worlds Largest Demo Plants for 2nd Generation Biofuel
5. World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol
6. Sequella and NIH Sign Exclusive Worldwide Licensing Agreement for SQ109 for New Infectious Disease Indications
7. Reportlinker Adds World Bioplastics Industry
8. Genomes of biofuel yeasts reveal clues that could boost fuel ethanol production worldwide
9. Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants
10. Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing
11. Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009
(Date:1/17/2017)... , Jan. 17, 2017  An international ... of Medicine and St. Boniface Hospital Albrechtsen Research ... peripheral neuropathy, an unmet health need affecting nearly ... Journal of Clinical Investigation, their results identify small ... prevent and reverse neuronal injury in animal models ...
(Date:1/17/2017)... LEXINGTON, Mass. , Jan. 17, 2017   ... clinical stage biopharmaceutical company developing innovative inhaled therapies to ... candidate for treating fungal infections in the lungs of ... Infectious Disease Product" (QIDP) by the U.S. Food & ... , which is designed to speed the development of ...
(Date:1/17/2017)... 17, 2017  Only nine percent of U.S. consumers ... while only 16 percent believe health insurance companies do, ... 36 percent of U.S. adults believe health care providers ... compared to hospitals (23%). "We are in ... Wendy Salomon , vice president of reputation management and ...
(Date:1/17/2017)... ... January 17, 2017 , ... Pono Ola , a mind-body wellness firm ... today the official launch of its much-anticipated Pono Board: a re-invented fitness and anti-fatigue ... development for over a year, the patented Pono Board is the world’s only exercise ...
Breaking Biology Technology:
(Date:1/18/2017)... , Jan. 18, 2017 MedNet ... that supports the entire spectrum of clinical research, ... another record-breaking year for the organization in terms ... in MedNet,s eClinical products and services. The company,s ... marketplace success of iMedNet ...
(Date:1/12/2017)... 12, 2017  Trovagene, Inc. (NASDAQ: TROV ... today announced that it has signed agreements with seven ... the Middle East for commercialization ... the first wave of international distribution agreements for Trovagene,s ... samples. The initial partners will introduce Trovagene,s ...
(Date:1/12/2017)... and PUNE, India , January 12, 2017 ... Opportunities and Forecasts, 2015 - 2022," projects that the global biometric technology market is ... 19.4% from 2016 to 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):